LEVODOPACARBIDOPA MYLAN

Main information

  • Trade name:
  • LEVODOPACARBIDOPA MYLAN Tablet 250MG/25MG
  • Dosage:
  • 250MG/25MG
  • Pharmaceutical form:
  • Tablet
  • Administration route:
  • Oral use
  • Units in package:
  • 100 Blister
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • LEVODOPACARBIDOPA MYLAN Tablet 250MG/25MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • LEVODOPA AND AN INHIBITOR OF DEKARBOXYLASY
  • Product summary:
  • LEVODOPA/CARBIDOPA MYLAN

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 27/ 044/13-C
  • Last update:
  • 05-04-2018